207 related articles for article (PubMed ID: 22998478)
21. [A process of programmed cell death as a mechanisms of neuronal death in prion diseases].
Chrétien F; Dorandeu A; Adle-Biassette H; Ereau T; Wingertsmann L; Brion F; Gray F
Clin Exp Pathol; 1999; 47(3-4):181-91. PubMed ID: 10472738
[TBL] [Abstract][Full Text] [Related]
22. Reduction of protein kinase MARK4 in the brains of experimental scrapie rodents and human prion disease correlates with deposits of PrP(Sc).
Gong HS; Guo Y; Tian C; Xie WL; Shi Q; Zhang J; Xu Y; Wang SB; Zhang BY; Chen C; Liu Y; Dong XP
Int J Mol Med; 2012 Sep; 30(3):569-78. PubMed ID: 22692785
[TBL] [Abstract][Full Text] [Related]
23. Extraneural manifestations of prion infection in GPI-anchorless transgenic mice.
Lee AM; Paulsson JF; Cruite J; Andaya AA; Trifilo MJ; Oldstone MB
Virology; 2011 Mar; 411(1):1-8. PubMed ID: 21227476
[TBL] [Abstract][Full Text] [Related]
24. PrP Knockout Cells Expressing Transmembrane PrP Resist Prion Infection.
Marshall KE; Hughson A; Vascellari S; Priola SA; Sakudo A; Onodera T; Baron GS
J Virol; 2017 Jan; 91(2):. PubMed ID: 27847358
[TBL] [Abstract][Full Text] [Related]
25. New Molecular Insight into Mechanism of Evolution of Mammalian Synthetic Prions.
Makarava N; Savtchenko R; Alexeeva I; Rohwer RG; Baskakov IV
Am J Pathol; 2016 Apr; 186(4):1006-14. PubMed ID: 26873446
[TBL] [Abstract][Full Text] [Related]
26. Genesis of mammalian prions: from non-infectious amyloid fibrils to a transmissible prion disease.
Makarava N; Kovacs GG; Savtchenko R; Alexeeva I; Budka H; Rohwer RG; Baskakov IV
PLoS Pathog; 2011 Dec; 7(12):e1002419. PubMed ID: 22144901
[TBL] [Abstract][Full Text] [Related]
27. Lack of prion infectivity in fixed heart tissue from patients with Creutzfeldt-Jakob disease or amyloid heart disease.
Priola SA; Ward AE; McCall SA; Trifilo M; Choi YP; Solforosi L; Williamson RA; Cruite JT; Oldstone MB
J Virol; 2013 Sep; 87(17):9501-10. PubMed ID: 23785217
[TBL] [Abstract][Full Text] [Related]
28. Prion protein transgenes and the neuropathology in prion diseases.
DeArmond SJ; Prusiner SB
Brain Pathol; 1995 Jan; 5(1):77-89. PubMed ID: 7767493
[TBL] [Abstract][Full Text] [Related]
29. Effectiveness of anthracycline against experimental prion disease in Syrian hamsters.
Tagliavini F; McArthur RA; Canciani B; Giaccone G; Porro M; Bugiani M; Lievens PM; Bugiani O; Peri E; Dall'Ara P; Rocchi M; Poli G; Forloni G; Bandiera T; Varasi M; Suarato A; Cassutti P; Cervini MA; Lansen J; Salmona M; Post C
Science; 1997 May; 276(5315):1119-22. PubMed ID: 9148807
[TBL] [Abstract][Full Text] [Related]
30. Breakage of PrP aggregates is essential for efficient autocatalytic propagation of misfolded prion protein.
Piening N; Weber P; Giese A; Kretzschmar H
Biochem Biophys Res Commun; 2005 Jan; 326(2):339-43. PubMed ID: 15582583
[TBL] [Abstract][Full Text] [Related]
31. Uptake and degradation of protease-sensitive and -resistant forms of abnormal human prion protein aggregates by human astrocytes.
Choi YP; Head MW; Ironside JW; Priola SA
Am J Pathol; 2014 Dec; 184(12):3299-307. PubMed ID: 25280631
[TBL] [Abstract][Full Text] [Related]
32. [Prion disease and brain amyloidosis].
Rukosuev VS; Zhavoronkov AA
Arkh Patol; 1999; 61(2):50-5. PubMed ID: 10412591
[TBL] [Abstract][Full Text] [Related]
33. Modulation of Glycosaminoglycans Affects PrPSc Metabolism but Does Not Block PrPSc Uptake.
Wolf H; Graßmann A; Bester R; Hossinger A; Möhl C; Paulsen L; Groschup MH; Schätzl H; Vorberg I
J Virol; 2015 Oct; 89(19):9853-64. PubMed ID: 26202247
[TBL] [Abstract][Full Text] [Related]
34. Isolation of infectious, non-fibrillar and oligomeric prions from a genetic prion disease.
Vanni I; Pirisinu L; Acevedo-Morantes C; Kamali-Jamil R; Rathod V; Di Bari MA; D'Agostino C; Marcon S; Esposito E; Riccardi G; Hornemann S; Senatore A; Aguzzi A; Agrimi U; Wille H; Nonno R
Brain; 2020 May; 143(5):1512-1524. PubMed ID: 32303068
[TBL] [Abstract][Full Text] [Related]
35. Intraspecies prion transmission results in selection of sheep scrapie strains.
Yokoyama T; Masujin K; Schmerr MJ; Shu Y; Okada H; Iwamaru Y; Imamura M; Matsuura Y; Murayama Y; Mohri S
PLoS One; 2010 Nov; 5(11):e15450. PubMed ID: 21103326
[TBL] [Abstract][Full Text] [Related]
36. Variably protease-sensitive prionopathy.
Notari S; Appleby BS; Gambetti P
Handb Clin Neurol; 2018; 153():175-190. PubMed ID: 29887135
[TBL] [Abstract][Full Text] [Related]
37. Evaluation of infective property of recombinant prion protein amyloids in cultured cells overexpressing cellular prion protein.
Kim DH; Lee HM; Ryou C
J Korean Med Sci; 2014 Dec; 29(12):1604-9. PubMed ID: 25469058
[TBL] [Abstract][Full Text] [Related]
38. Familial human prion diseases associated with prion protein mutations Y226X and G131V are transmissible to transgenic mice expressing human prion protein.
Race B; Williams K; Hughson AG; Jansen C; Parchi P; Rozemuller AJM; Chesebro B
Acta Neuropathol Commun; 2018 Feb; 6(1):13. PubMed ID: 29458424
[TBL] [Abstract][Full Text] [Related]
39. No influence of amyloid-beta-degrading neprilysin activity on prion pathogenesis.
Glatzel M; Mohajeri MH; Poirier R; Nitsch RM; Schwarz P; Lu B; Aguzzi A
J Gen Virol; 2005 Jun; 86(Pt 6):1861-1867. PubMed ID: 15914866
[TBL] [Abstract][Full Text] [Related]
40. Reconstitution of prion infectivity from solubilized protease-resistant PrP and nonprotein components of prion rods.
Shaked GM; Meiner Z; Avraham I; Taraboulos A; Gabizon R
J Biol Chem; 2001 Apr; 276(17):14324-8. PubMed ID: 11152454
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
